
ATRIUM THERAPEUTICS INC (RNA) Stock Balance Sheet
NASDAQ:RNA • US04965N1046
Current stock price
13.44 USD
-0.03 (-0.22%)
At close:
13.44 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | N/A | 219.87M | 185.08M | 340.40M | 320.40M | |||
| Marketable Securities | N/A | 1.28B | 410.27M | 270.30M | 85.10M | |||
| Receivables | 100.00K | 28.22M | 1.10M | N/A | N/A | |||
| Other Current Assets | 2.75M | 483.00K | 856.00K | 12.20M | 5.60M | |||
| Total Current Assets | 2.85M | 483.00K | 856.00K | 622.90M | 411.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.51M | 6.70M | 9.44M | 15.00M | 15.60M | |||
| Other Non-Current Assets | N/A | 3.32M | 596.00K | 800.00K | 900.00K | |||
| Total Non-Current Assets | 5.51M | 6.70M | 9.44M | 15.90M | 16.50M | |||
| TOTAL ASSETS | 8.35M | 7.19M | 10.29M | 638.80M | 427.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 15.76M | 5.28M | 5.14M | 14.30M | 10.70M | |||
| Accounts Payable | 4.40M | 532.00K | 498.00K | 32.60M | 14.10M | |||
| Other Current Liabilities | 21.64M | 20.99M | 28.16M | 5.00M | 4.90M | |||
| Total Current Liabilities | 41.80M | 26.80M | 33.80M | 51.90M | 29.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 29.27M | 41.49M | 47.11M | 8.80M | 16.50M | |||
| Total Non-Current Liabilities | 29.27M | 41.49M | 47.11M | 8.80M | 16.50M | |||
| TOTAL LIABILITIES | 71.07M | 68.29M | 80.91M | 60.70M | 46.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | N/A | -893.07M | -570.76M | -358.50M | -184.50M | |||
| Additional Paid In Capital | N/A | 2.32B | 1.07B | 939.30M | 566.20M | |||
| Common Shares | N/A | 12.00K | 8.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -62.71M | -61.11M | -70.62M | -2.70M | -200.00K | |||
| Shares Outstanding | 17.11M | 17.11M | 17.11M | 69.80M | 47.80M | |||
| Tangible Book Value per Share | -3.66 | -3.57 | -4.13 | 8.28 | 7.98 | |||
| Total Shareholders' Equity | -62.71M | -61.11M | -70.62M | 578.10M | 381.40M | |||
| TOTAL LIABILITIES AND EQUITY | 8.35M | 7.19M | 10.29M | 638.80M | 427.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 0.07 | 0.02 | 0.03 | 12.00 | 13.84 | |||
| Return On Assets (ROA) | -592.61% | -349.60% | -62.03% | -27.24% | -27.60% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -30.10% | -30.94% | |||
All data in USD , ROIC based on taxRate of 0.21